BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15257518)

  • 1. High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.
    Kehrer-Sawatzki H; Kluwe L; Sandig C; Kohn M; Wimmer K; Krammer U; Peyrl A; Jenne DE; Hansmann I; Mautner VF
    Am J Hum Genet; 2004 Sep; 75(3):410-23. PubMed ID: 15257518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.
    Steinmann K; Cooper DN; Kluwe L; Chuzhanova NA; Senger C; Serra E; Lazaro C; Gilaberte M; Wimmer K; Mautner VF; Kehrer-Sawatzki H
    Am J Hum Genet; 2007 Dec; 81(6):1201-20. PubMed ID: 17999360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).
    Messiaen L; Vogt J; Bengesser K; Fu C; Mikhail F; Serra E; Garcia-Linares C; Cooper DN; Lazaro C; Kehrer-Sawatzki H
    Hum Mutat; 2011 Feb; 32(2):213-9. PubMed ID: 21280148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2.
    Kehrer-Sawatzki H; Kluwe L; Fünsterer C; Mautner VF
    Hum Genet; 2005 May; 116(6):466-75. PubMed ID: 15776250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
    Kehrer-Sawatzki H; Vogt J; Mußotter T; Kluwe L; Cooper DN; Mautner VF
    Neurogenetics; 2012 Aug; 13(3):229-36. PubMed ID: 22581253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations.
    Petek E; Jenne DE; Smolle J; Binder B; Lasinger W; Windpassinger C; Wagner K; Kroisel PM; Kehrer-Sawatzki H
    J Med Genet; 2003 Jul; 40(7):520-5. PubMed ID: 12843325
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorder.
    Vogt J; Mussotter T; Bengesser K; Claes K; Högel J; Chuzhanova N; Fu C; van den Ende J; Mautner VF; Cooper DN; Messiaen L; Kehrer-Sawatzki H
    Hum Mutat; 2012 Nov; 33(11):1599-609. PubMed ID: 22837079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination.
    Bengesser K; Vogt J; Mussotter T; Mautner VF; Messiaen L; Cooper DN; Kehrer-Sawatzki H
    Hum Mutat; 2014 Feb; 35(2):215-26. PubMed ID: 24186807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1.
    Rasmussen SA; Colman SD; Ho VT; Abernathy CR; Arn PH; Weiss L; Schwartz C; Saul RA; Wallace MR
    J Med Genet; 1998 Jun; 35(6):468-71. PubMed ID: 9643287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions.
    Roehl AC; Vogt J; Mussotter T; Zickler AN; Spöti H; Högel J; Chuzhanova NA; Wimmer K; Kluwe L; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    Hum Mutat; 2010 Oct; 31(10):1163-73. PubMed ID: 20725927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2021 Dec; 140(12):1635-1649. PubMed ID: 34535841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2.
    Bengesser K; Cooper DN; Steinmann K; Kluwe L; Chuzhanova NA; Wimmer K; Tatagiba M; Tinschert S; Mautner VF; Kehrer-Sawatzki H
    Hum Mutat; 2010 Jun; 31(6):742-51. PubMed ID: 20506354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
    Kehrer-Sawatzki H; Mautner VF; Cooper DN
    Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions.
    Neuhäusler L; Summerer A; Cooper DN; Mautner VF; Kehrer-Sawatzki H
    Hum Genet; 2018 May; 137(5):365-373. PubMed ID: 29730711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.
    Kehrer-Sawatzki H; Schmid E; Fünsterer C; Kluwe L; Mautner VF
    Am J Med Genet A; 2008 Mar; 146A(6):691-9. PubMed ID: 18265407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-deep amplicon sequencing indicates absence of low-grade mosaicism with normal cells in patients with type-1 NF1 deletions.
    Summerer A; Schäfer E; Mautner VF; Messiaen L; Cooper DN; Kehrer-Sawatzki H
    Hum Genet; 2019 Jan; 138(1):73-81. PubMed ID: 30478644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended runs of homozygosity at 17q11.2: an association with type-2 NF1 deletions?
    Roehl AC; Cooper DN; Kluwe L; Helbrich A; Wimmer K; Högel J; Mautner VF; Kehrer-Sawatzki H
    Hum Mutat; 2010 Mar; 31(3):325-34. PubMed ID: 20052761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism.
    Lázaro C; Gaona A; Lynch M; Kruyer H; Ravella A; Estivill X
    Am J Hum Genet; 1995 Nov; 57(5):1044-9. PubMed ID: 7485153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.
    Jenne DE; Tinschert S; Reimann H; Lasinger W; Thiel G; Hameister H; Kehrer-Sawatzki H
    Am J Hum Genet; 2001 Sep; 69(3):516-27. PubMed ID: 11468690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata.
    Leppig KA; Kaplan P; Viskochil D; Weaver M; Ortenberg J; Stephens K
    Am J Med Genet; 1997 Dec; 73(2):197-204. PubMed ID: 9409873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.